Cisplatin resistance-related multi-omics differences and the establishment of machine learning models

Abstract Objectives Platinum-based chemotherapies are currently the first-line treatment of non-small cell lung cancer. This study will improve our understanding of the causes of resistance to cisplatin, especially in lung adenocarcinoma (LUAD) and provide a reference for therapeutic decisions in cl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qihai Sui, Zhencong Chen, Zhengyang Hu, Yiwei Huang, Jiaqi Liang, Guoshu Bi, Yunyi Bian, Mengnan Zhao, Cheng Zhan, Zongwu Lin, Qun Wang, Lijie Tan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-04-01
coleção:	Journal of Translational Medicine
Assuntos:	Cisplatin Drug resistance Machine learning IC50
Acesso em linha:	https://doi.org/10.1186/s12967-022-03372-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!